Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, has scheduled its fourth quarter and year-end 2024 financial results announcement for Wednesday, March 12, 2025, after market close.
The company will host an investor conference call at 5:00 p.m. ET on the same day to discuss financial results and business highlights. Investors can join via phone using the toll-free domestic number 1-800-717-1738 or international number 1-646-307-1865 with conference ID 89368. A live audio webcast and presentation materials will be available on Anika's website investor relations section.
Anika Therapeutics (NASDAQ: ANIK), un'azienda globale specializzata nella preservazione delle articolazioni e focalizzata sull'ortopedia d'intervento precoce, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'anno 2024 per mercoledì 12 marzo 2025, dopo la chiusura del mercato.
L'azienda ospiterà una conference call per gli investitori alle 17:00 ET dello stesso giorno per discutere i risultati finanziari e i punti salienti aziendali. Gli investitori possono partecipare telefonicamente utilizzando il numero verde nazionale 1-800-717-1738 o il numero internazionale 1-646-307-1865 con ID conferenza 89368. Sarà disponibile una diretta audio e materiali di presentazione nella sezione relazioni con gli investitori del sito web di Anika.
Anika Therapeutics (NASDAQ: ANIK), una empresa global dedicada a la preservación articular y centrada en la ortopedia de intervención temprana, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año 2024 para miércoles, 12 de marzo de 2025, después del cierre del mercado.
La empresa llevará a cabo una llamada de conferencia para inversores a las 5:00 p.m. ET el mismo día para discutir los resultados financieros y los aspectos destacados del negocio. Los inversores pueden unirse por teléfono usando el número gratuito nacional 1-800-717-1738 o el número internacional 1-646-307-1865 con el ID de conferencia 89368. Se dispondrá de una transmisión de audio en vivo y materiales de presentación en la sección de relaciones con inversores del sitio web de Anika.
아니카 테라퓨틱스 (NASDAQ: ANIK), 조기介入 정형외과에 중점을 둔 글로벌 관절 보존 회사가 2025년 3월 12일 수요일에 2024년 4분기 및 연간 재무 결과 발표를 시장 마감 후로 예정했습니다.
회사는 같은 날 오후 5시 ET에 재무 결과 및 사업 하이라이트를 논의하기 위해 투자자 컨퍼런스 콜을 개최할 예정입니다. 투자자는 무료 국내 전화번호 1-800-717-1738 또는 국제 전화번호 1-646-307-1865로 컨퍼런스 ID 89368을 사용하여 참여할 수 있습니다. 아니카 웹사이트의 투자자 관계 섹션에서 라이브 오디오 웹캐스트 및 발표 자료를 이용할 수 있습니다.
Anika Therapeutics (NASDAQ: ANIK), une entreprise mondiale spécialisée dans la préservation des articulations et axée sur l'orthopédie d'intervention précoce, a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année 2024 pour mercredi 12 mars 2025, après la fermeture du marché.
L'entreprise organisera une conférence téléphonique pour les investisseurs à 17h00 ET le même jour pour discuter des résultats financiers et des points forts de l'entreprise. Les investisseurs peuvent se joindre par téléphone en utilisant le numéro gratuit national 1-800-717-1738 ou le numéro international 1-646-307-1865 avec l'ID de conférence 89368. Un webinaire audio en direct et des documents de présentation seront disponibles dans la section relations avec les investisseurs du site web d'Anika.
Anika Therapeutics (NASDAQ: ANIK), ein globales Unternehmen zur Erhaltung von Gelenken, das sich auf die frühzeitige Intervention in der Orthopädie konzentriert, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das Jahr 2024 auf Mittwoch, den 12. März 2025, nach Börsenschluss festgelegt.
Das Unternehmen wird am selben Tag um 17:00 Uhr ET eine Telefonkonferenz für Investoren abhalten, um die finanziellen Ergebnisse und Unternehmenshighlights zu besprechen. Investoren können über die gebührenfreie nationale Nummer 1-800-717-1738 oder die internationale Nummer 1-646-307-1865 mit der Konferenz-ID 89368 teilnehmen. Eine Live-Audioübertragung und Präsentationsmaterialien werden im Bereich Investor Relations auf der Website von Anika verfügbar sein.
- None.
- None.
BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its fourth quarter and year-end 2024 financial results after the close of the market on Wednesday, March 12, 2025 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 89368. A live audio webcast and accompanying presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When will Anika Therapeutics (ANIK) release Q4 and full-year 2024 earnings?
How can investors access ANIK's Q4 2024 earnings call?
What time is Anika's (ANIK) Q4 2024 earnings conference call?
Where can I find ANIK's Q4 2024 earnings presentation materials?
